Revised model for cell cycle regulation by iron: differential roles between transferrin and ferritin
Ryo Yanagiya,
Hiroko Kato,
Akinori Ninomiya,
Masaya Ueno,
Akane Kanamori,
Yuji Miyatake,
Masahiro Oka,
Keisuke Ishii,
Tadashi Matsuura,
So Nakagawa,
Atsushi Hirao,
Makoto Onizuka,
Ai Kotani
Affiliations
Ryo Yanagiya
Department of Regulation of Infectious Cancers, Research Institute for Microbial Diseases, The University of Osaka, Suita, Japan; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan; Department of Drug Discovery and Biomedical Sciences, Faculty of Medicine, Saga University, Saga, Japan
Hiroko Kato
Core Instrumentation Facility, Immunology Frontier Research Center, The University of Osaka, Suita, Japan
Akinori Ninomiya
Central Instrumentation Laboratory, Research Institute for Microbial Diseases, The University of Osaka, Suita, Japan
Masaya Ueno
Division of Molecular Genetics, Cancer and Stem Cell Research Program, Cancer Research Institute, Kanazawa University, Kakuma-machi, Kanazawa, Japan; WPI Nano Life Science Institute (WPI-Nano LSI), Kanazawa University, Kakuma-machi, Kanazawa, Japan
Akane Kanamori
Department of Regulation of Infectious Cancers, Research Institute for Microbial Diseases, The University of Osaka, Suita, Japan
Yuji Miyatake
Department of Regulation of Infectious Cancers, Research Institute for Microbial Diseases, The University of Osaka, Suita, Japan
Masahiro Oka
Department of Regulation of Infectious Cancers, Research Institute for Microbial Diseases, The University of Osaka, Suita, Japan
Keisuke Ishii
Perseus Proteomics, Inc., Tokyo, Japan
Tadashi Matsuura
Perseus Proteomics, Inc., Tokyo, Japan
So Nakagawa
Department of Molecular Life Science, Tokai University School of Medicine, Isehara, Japan; Division of Omics Sciences, Institute of Medical Sciences, Tokai University, Isehara, Japan; Division of Interdisciplinary Merging of Health Research, Micro/Nano Technology Center, Tokai University, Hiratsuka, Japan
Atsushi Hirao
Division of Molecular Genetics, Cancer and Stem Cell Research Program, Cancer Research Institute, Kanazawa University, Kakuma-machi, Kanazawa, Japan; WPI Nano Life Science Institute (WPI-Nano LSI), Kanazawa University, Kakuma-machi, Kanazawa, Japan
Makoto Onizuka
Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan
Ai Kotani
Department of Regulation of Infectious Cancers, Research Institute for Microbial Diseases, The University of Osaka, Suita, Japan; Corresponding author. Department of Regulation of Infectious Cancers, Research Institute for Microbial Diseases, The University of Osaka, 3-1 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Iron is essential for neoplasms including natural killer (NK) cell lymphoma, and mainly supplemented by transferrin and stored by ferritin. Although accumulating studies had demonstrated that iron chelation arrests cell cycle progression at G1 phase, our previous studies showed the induction of DNA double strand break at S phase cell cycle without G1 arrest by selective inhibition of cellular transferrin uptake, indicating that the existence of some undiscovered differences in the roles of the two major iron sources for cell cycle regulation. In this study, we identified a novel cell cycle regulation of transferrin binding iron in NK cell lymphoma. Blocking transferrin uptake induced S phase arrest owing to the dysfunction of nascent DNA synthesis. Moreover, canonical G1 arrest was observed with mitochondrial dysfunction followed by downregulation of mTORC1 and dephosphorylation of Rb only when intracellular iron storage was deprived by iron chelation. These results suggested that iron is critically involved in at least two steps of the cell cycle: the S phase and G1/S transition. Especially, considering the toxicity of mitochondrial dysfunction to normal cells and cell cycle dependent manner of S phase-specific DNA damage due to selective inhibition of transferrin uptake, transferrin receptor blockers are thought to be more suitable than iron chelators as antineoplastic agents. Overall, the current canonical model of cell cycle regulation by iron requires revision.